Title : Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2.

Pub. Date : 2022 Feb 17

PMID : 35214780






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2. azd1222 surface glycoprotein Severe acute respiratory syndrome coronavirus 2
2 In contrast, the heterologous prime-boost regimen using AZD1222 and BNT162b2 yielded the highest anti-spike IgG levels, which were 3-4.5 times more than the levels resulting from homologous AZD1222 and BNT162b2 vaccination, respectively. azd1222 surface glycoprotein Severe acute respiratory syndrome coronavirus 2
3 In contrast, the heterologous prime-boost regimen using AZD1222 and BNT162b2 yielded the highest anti-spike IgG levels, which were 3-4.5 times more than the levels resulting from homologous AZD1222 and BNT162b2 vaccination, respectively. azd1222 surface glycoprotein Severe acute respiratory syndrome coronavirus 2